{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:08:21Z","timestamp":1792490901624,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotoxicology and Teratology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ntt.2013.01.004","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T06:17:37Z","timestamp":1360304257000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":384,"special_numbering":"C","title":["In utero exposure to valproic acid and autism \u2014 A current review of clinical and animal studies"],"prefix":"10.1016","volume":"36","author":[{"given":"Florence I.","family":"Roullet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan K.Y.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ntt.2013.01.004_bb0005","series-title":"Diagnostic and statistical manual of mental disorder (DSM-IV), Washington, DC","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.ntt.2013.01.004_bb0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tins.2009.04.003","article-title":"The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders","volume":"32","author":"Betancur","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.ntt.2013.01.004_bb0015","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2013.01.004_bb0020","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/088307380201700908","article-title":"Clinical and macroscopic correlates of minicolumnar pathology in autism","volume":"17","author":"Casanova","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0025","first-page":"1","article-title":"Prevalence of autism spectrum disorders \u2014 Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.ntt.2013.01.004_bb0030","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2009.142","article-title":"Affect of seizures during gestation on pregnancy outcomes in women with epilepsy","volume":"66","author":"Chen","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","article-title":"Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs","volume":"36","author":"Christianson","year":"1994","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mrdd.20039","article-title":"Designing mouse behavioral tasks relevant to autistic-like behaviors","volume":"10","author":"Crawley","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.ntt.2013.01.004_bb0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ntt.2013.01.004_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2009.12.054","article-title":"Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism","volume":"470","author":"Dufour-Rainfray","year":"2010","journal-title":"Neurosci Lett"},{"issue":"Suppl. 2","key":"10.1016\/j.ntt.2013.01.004_bb0055","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/sj.mp.4001162","article-title":"Epidemiological trends in rates of autism","volume":"7","author":"Fombonne","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ntt.2013.01.004_bb0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1023\/A:1025054610557","article-title":"Epidemiological surveys of autism and other pervasive developmental disorders: an update","volume":"33","author":"Fombonne","year":"2003","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.ntt.2013.01.004_bb0065","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1528-1167.2008.01943.x","article-title":"Dose-dependent memory effects and cerebral volume changes after in utero exposure to valproate in the rat","volume":"50","author":"Frisch","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ntt.2013.01.004_bb0070","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0890-6238(02)00059-X","article-title":"Neural crest cell motility in valproic acid","volume":"16","author":"Fuller","year":"2002","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0075","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.biopsych.2010.09.031","article-title":"Validating gamma oscillations and delayed auditory responses as translational biomarkers of autism","volume":"68","author":"Gandal","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ntt.2013.01.004_bb0080","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.neubiorev.2009.11.017","article-title":"Circadian rhythms and sleep in children with autism","volume":"34","author":"Glickman","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.ntt.2013.01.004_bb0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1423-0127-18-48","article-title":"Valproic acid inhibits neural progenitor cell death by activation of NF-kappaB signaling pathway and up-regulation of Bcl-XL","volume":"18","author":"Go","year":"2011","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.ntt.2013.01.004_bb0090","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.ntt.2013.01.004_bb0095","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaac.2010.05.005","article-title":"Autism spectrum disorders and epigenetics","volume":"49","author":"Grafodatskaya","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ntt.2013.01.004_bb0100","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1528-1167.2009.02128.x","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ntt.2013.01.004_bb0105","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2009.02129.x","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ntt.2013.01.004_bb0110","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1528-1167.2009.02130.x","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ntt.2013.01.004_bb0115","doi-asserted-by":"crossref","first-page":"e41280","DOI":"10.1371\/journal.pone.0041280","article-title":"Autism spectrum disorders in the Stockholm Youth Cohort: design, prevalence and validity","volume":"7","author":"Idring","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ntt.2013.01.004_bb0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0892-0362(99)00083-5","article-title":"Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism","volume":"22","author":"Ingram","year":"2000","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0125","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ntt.2013.01.004_bb0130","first-page":"1","article-title":"Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid","author":"Kataoka","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","article-title":"The critical period of valproate exposure to induce autistic symptoms in Sprague\u2013Dawley rats","volume":"201","author":"Kim","year":"2011","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.ntt.2013.01.004_bb0140","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.neuroscience.2009.07.021","article-title":"Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice","volume":"163","author":"Kolozsi","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.ntt.2013.01.004_bb0145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.c.31330","article-title":"Network- and attribute-based classifiers can prioritize genes and pathways for autism spectrum disorders and intellectual disability","volume":"160C","author":"Kou","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ntt.2013.01.004_bb0150","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.seizure.2011.06.012","article-title":"Antiepileptic drug use during pregnancy: perinatal outcomes","volume":"20","author":"Kulaga","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.ntt.2013.01.004_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0160","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1471-4159.2009.06385.x","article-title":"Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation","volume":"111","author":"Marinova","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.ntt.2013.01.004_bb0165","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.npp.1301453","article-title":"Abnormal fear conditioning and amygdala processing in an animal model of autism","volume":"33","author":"Markram","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ntt.2013.01.004_bb0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.seizure.2012.01.005","article-title":"Valproate and the risk for congenital malformations: is formulation and dosage regime important?","volume":"21","author":"Mawhinney","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.ntt.2013.01.004_bb0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1535-7511.2005.05305.x","article-title":"Valproate poses risk to unborn child","volume":"5","author":"Meador","year":"2005","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.ntt.2013.01.004_bb0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1535-7511.2008.00273.x","article-title":"Effects of in utero antiepileptic drug exposure","volume":"8","author":"Meador","year":"2008","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.ntt.2013.01.004_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ntt.2013.01.004_bb0190","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ntt.2013.01.004_bb0195","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/brain\/awq352","article-title":"Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age","volume":"134","author":"Meador","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ntt.2013.01.004_bb0200","doi-asserted-by":"crossref","first-page":"e26077","DOI":"10.1371\/journal.pone.0026077","article-title":"mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism","volume":"6","author":"Mehta","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ntt.2013.01.004_bb0205","first-page":"435","article-title":"Pharmacodynamic properties of N-dipropylacetic acid","volume":"18","author":"Meunier","year":"1963","journal-title":"Therapie"},{"key":"10.1016\/j.ntt.2013.01.004_bb0210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1874467210902010095","article-title":"Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection","volume":"2","author":"Monti","year":"2009","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1601-1848.2004.00076.x","article-title":"Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice","volume":"3","author":"Moy","year":"2004","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.ntt.2013.01.004_bb0220","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S1355617710001359","article-title":"The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy","volume":"17","author":"Nadebaum","year":"2011","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.ntt.2013.01.004_bb0225","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/WNL.0b013e31820d62c7","article-title":"Language skills of school-aged children prenatally exposed to antiepileptic drugs","volume":"76","author":"Nadebaum","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2013.01.004_bb0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archgenpsychiatry.2009.137","article-title":"Brain serotonin and dopamine transporter bindings in adults with high-functioning autism","volume":"67","author":"Nakamura","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ntt.2013.01.004_bb0235","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2007.11.043","article-title":"Swim stress exaggerates the hyperactive mesocortical dopamine system in a rodent model of autism","volume":"1193","author":"Nakasato","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.ntt.2013.01.004_bb0240","first-page":"576","article-title":"Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism","volume":"52","author":"Narita","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ntt.2013.01.004_bb0245","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neures.2009.09.001","article-title":"Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat","volume":"66","author":"Narita","year":"2010","journal-title":"Neurosci Res"},{"key":"10.1016\/j.ntt.2013.01.004_bb0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/bdra.20131","article-title":"Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice","volume":"73","author":"Okada","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0260","first-page":"396","article-title":"The U.S. Food and Drug Administration (FDA) has assigned pregnancy category D to valproate","volume":"71","author":"Peckman","year":"2010","journal-title":"N C Med J"},{"key":"10.1016\/j.ntt.2013.01.004_bb0265","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ncl.2004.07.004","article-title":"Pregnancy in women who have epilepsy","volume":"22","author":"Pennell","year":"2004","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ntt.2013.01.004_bb0270","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.expneurol.2010.12.025","article-title":"Early valproic acid exposure alters functional organization in the primary visual cortex","volume":"228","author":"Pohl-Guimaraes","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0275","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0280","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/neuro.04.004.2008","article-title":"Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism","volume":"2","author":"Rinaldi","year":"2008","journal-title":"Front Neural Circuits"},{"key":"10.1016\/j.ntt.2013.01.004_bb0285","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/cercor\/bhm117","article-title":"Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid","volume":"18","author":"Rinaldi","year":"2008","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.ntt.2013.01.004_bb0290","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2","article-title":"Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei","volume":"370","author":"Rodier","year":"1996","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0295","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0890-6238(97)80001-U","article-title":"Linking etiologies in humans and animal models: studies of autism","volume":"11","author":"Rodier","year":"1997","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0300","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/7854_2010_113","article-title":"Mouse models of autism: testing hypotheses about molecular mechanisms","volume":"7","author":"Roullet","year":"2011","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.ntt.2013.01.004_bb0305","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuroscience.2010.06.069","article-title":"Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid","volume":"170","author":"Roullet","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.ntt.2013.01.004_bb0310","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(61)80261-8","article-title":"Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children","volume":"58","author":"Schain","year":"1961","journal-title":"J Pediatr"},{"key":"10.1016\/j.ntt.2013.01.004_bb0315","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00439-011-1037-2","article-title":"Risk factors for autism: translating genomic discoveries into diagnostics","volume":"130","author":"Scherer","year":"2011","journal-title":"Hum Genet"},{"key":"10.1016\/j.ntt.2013.01.004_bb0320","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ntt.2013.01.004_bb0325","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.npp.1300767","article-title":"Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism","volume":"31","author":"Schneider","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ntt.2013.01.004_bb0330","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","article-title":"Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid","volume":"33","author":"Schneider","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ntt.2013.01.004_bb0335","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00148581-200709050-00006","article-title":"Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents","volume":"9","author":"Scott","year":"2007","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.ntt.2013.01.004_bb0340","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1212\/WNL.0b013e3182088297","article-title":"Child development following in utero exposure: levetiracetam vs sodium valproate","volume":"76","author":"Shallcross","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ntt.2013.01.004_bb0345","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/dev.20337","article-title":"Altered morphology of motor cortex neurons in the VPA rat model of autism","volume":"50","author":"Snow","year":"2008","journal-title":"Dev Psychobiol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0350","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2006.10.022","article-title":"Discrimination learning and reversal of the conditioned eyeblink reflex in a rodent model of autism","volume":"176","author":"Stanton","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.ntt.2013.01.004_bb0355","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.brainresbull.2012.01.011","article-title":"Prenatal exposure to valproic acid enhances synaptic plasticity in the medial prefrontal cortex and fear memories","volume":"87","author":"Sui","year":"2012","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.ntt.2013.01.004_bb0360","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijdevneu.2011.03.008","article-title":"Morphological abnormalities of embryonic cranial nerves after in utero exposure to valproic acid: implications for the pathogenesis of autism with multiple developmental anomalies","volume":"29","author":"Tashiro","year":"2011","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.ntt.2013.01.004_bb0365","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-3-642-20195-0_15","article-title":"Antiepileptic treatment in pregnant women: morphological and behavioural effects","volume":"205","author":"Tomson","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0370","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0375","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neures.2006.10.018","article-title":"Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism","volume":"57","author":"Tsujino","year":"2007","journal-title":"Neurosci Res"},{"key":"10.1016\/j.ntt.2013.01.004_bb0380","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.taap.2010.08.001","article-title":"Epigenetic modifications in valproic acid-induced teratogenesis","volume":"248","author":"Tung","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0385","author":"US Food and Drug Administration"},{"key":"10.1016\/j.ntt.2013.01.004_bb0390","author":"US Food and Drug Administration"},{"key":"10.1016\/j.ntt.2013.01.004_bb0395","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1479-828X.2007.00781.x","article-title":"The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies","volume":"47","author":"Vajda","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0400","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0404.2009.01260.x","article-title":"Changing patterns of antiepileptic drug use in pregnant Australian women","volume":"121","author":"Vajda","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ntt.2013.01.004_bb0405","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1479-828X.2011.01359.x","article-title":"The prescribing of antiepileptic drugs for pregnant Australian women","volume":"52","author":"Vajda","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0410","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1073\/pnas.1112345109","article-title":"Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior","volume":"109","author":"Veenstra-VanderWeele","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ntt.2013.01.004_bb0415","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10803-006-0117-y","article-title":"A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate","volume":"36","author":"Wagner","year":"2006","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.ntt.2013.01.004_bb0420","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1523\/JNEUROSCI.1341-11.2011","article-title":"Synaptic and intrinsic balancing during postnatal development in rat pups exposed to valproic acid in utero","volume":"31","author":"Walcott","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.ntt.2013.01.004_bb0425","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.annepidem.2011.08.002","article-title":"Use of antiepileptic medications in pregnancy in relation to risks of birth defects","volume":"21","author":"Werler","year":"2011","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0430","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1469-8749.1997.tb07500.x","article-title":"A male with fetal valproate syndrome and autism","volume":"39","author":"Williams","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0435","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-8749.2001.tb00188.x","article-title":"Fetal valproate syndrome and autism: additional evidence of an association","volume":"43","author":"Williams","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ntt.2013.01.004_bb0440","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1601-183X.2010.00582.x","article-title":"Reduced scent marking and ultrasonic vocalizations in the BTBR T+tf\/J mouse model of autism","volume":"10","author":"Wohr","year":"2011","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.ntt.2013.01.004_bb0445","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neuropharm.2008.09.019","article-title":"Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation","volume":"56","author":"Yu","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ntt.2013.01.004_bb0450","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s11064-012-0724-2","article-title":"Downregulating the canonical Wnt\/beta-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress","volume":"37","author":"Zhang","year":"2012","journal-title":"Neurochem Res"}],"container-title":["Neurotoxicology and Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036213000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036213000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:18:07Z","timestamp":1760210287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892036213000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":90,"alternative-id":["S0892036213000056"],"URL":"https:\/\/doi.org\/10.1016\/j.ntt.2013.01.004","relation":{},"ISSN":["0892-0362"],"issn-type":[{"value":"0892-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In utero exposure to valproic acid and autism \u2014 A current review of clinical and animal studies","name":"articletitle","label":"Article Title"},{"value":"Neurotoxicology and Teratology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ntt.2013.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}